GSK Licenses Idenix’s HIV Drug
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 2 (Table of Contents)
Published: 6 Feb-2009
DOI: 10.3833/pdr.v2009.i2.84 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
GSK has acquired worldwide rights to an oral non-nucleoside reverse transcriptase inhibitor, IDX899, from Idenix Pharmaceuticals...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS